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MODS Assay for the Diagnosis of TB
To the Editor: In their article on the use of mi-
croscopic-observation drug-susceptibility (MODS) 
culture for the diagnosis and direct detection of 
multidrug-resistant tuberculosis, Moore et al. (Oct. 
12 issue)1 state that MODS culture offers faster 
and more sensitive results than existing gold-
standard methods. This study is one of the few 
performed in a target population with a rather 
simple and inexpensive method that seems to be 
appropriate for countries with limited resources.
However, we would like to stress that there are 
other options that have recently been described2 
and are currently under evaluation. As compared 
with MODS culture, the nitrate reduction assay, 
based on a simple procedure involving the use of 
Löwenstein–Jensen medium, has been tested in 
sputum samples with similarly good results.3 The 
thin-layer agar method, which is similar to MODS 
culture but with solid medium and standard mi-
croscopes, had better results than conventional 
methods when evaluated in target populations.4 
In ongoing evaluations, the thin-layer agar meth-
od has also outperformed the reference method 
for detecting multidrug-resistant tuberculosis. In 
addition, direct colorimetric methods with redox 
indicators have performed very well5 and are 
under further evaluation. A disadvantage of the 
MODS method remains the requirement of an 
inverted microscope, which is not routinely avail-
able in laboratories that perform diagnostic tests 
for tuberculosis.
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To the Editor: The MODS assay has certain lim-
itations. Microscopical differentiation between mi-
crocolonies of Mycobacterium tuberculosis and those 
of rapidly growing mycobacteria may be difficult. 
The assay requires daily examination, is time-
consuming, and as highlighted by Iseman and 
Heifets,1 carries a risk of laboratory transmission. 
We therefore agree that the microscopical-obser-
vation method, although promising, will require 
modification and adaptation before it can be rec-
ommended for widespread use.
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The Authors Reply: Although there is merit in 
the alternative methods Palomino and colleagues 
mention, elements of which gave rise to the MODS 
assay, the culture time for the Löwenstein–Jensen–
based nitrate reduction assay is three to four times 
that for the MODS assay, with lower sensitivity, 
and as with the direct colorimetric assay, data for 
smear-negative samples are lacking. Unlike MODS 
culture, both techniques involve the potentially 
hazardous opening of mature tuberculosis cul-
tures to add a specific reagent. The thin-layer agar 
method is rapid, but its sensitivity is usually lower 
and its contamination rate higher than those of 
the Löwenstein–Jensen method, and no data on 
drug-susceptibility testing have been published.
In our opinion, MODS culture is actually safer 
than any indirect drug-susceptibility testing meth-
od, since culture amplification and direct drug-
susceptibility testing occur within a closed system: 
the MODS plate is inoculated and then sealed 
within a ziplock bag. It is not manipulated again, 
since all readings, including those for drug-sus-
ceptibility testing, are done through the bag. The 
handling of cultured M. tuberculosis at bacterial 
concentrations thousands of times those of clini-
cal specimens, which is required for secondary 
drug-susceptibility testing, dwarfs the biohazard 
risk associated with sputum-decontamination 
processes common to all culture methods. This 
handling risk is entirely avoided with the MODS 
assay.
Hasan and Irfan did not use ziplock bags, be-
cause this important detail was omitted from 
previous articles on the MODS assay.1-3 We do not 
believe that a MODS laboratory needs to meet 
biosafety level 3 standards. Combining the use by 
laboratory staff of respirators approved by the 
National Institute for Occupational Safety and 
Health and appropriate protective clothing with 
a well-positioned, properly maintained class II 
biologic safety cabinet that recirculates exhausted 
air through a high-efficiency particulate air (HEPA) 
filter into a closed room, should be adequate. With 
respect to rapidly growing mycobacteria, these 
organisms should overgrow MODS plates by day 5, 
a phenomenon not seen with M. tuberculosis.
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Refining Prognosis in Non–Small-Cell Lung Cancer
To the Editor: Potti et al. (Aug. 10 issue)1 apply 
a metagene model to the profiling of non–small-
cell lung cancer (NSCLC) and demonstrate supe-
rior performance in predicting tumor recurrence 
and survival, as compared with a clinical model. 
We believe that the impressively contrasting re-
sults could be partially due to the incompleteness 
of the clinical model the authors used. Classify-
ing NSCLC into squamous-cell carcinoma and ade-
nocarcinoma has not been predictive for prognosis 
in general. However, subtypes of adenocarcino-
ma — bronchioloalveolar carcinoma and mixed 
adenocarcinoma with a bronchioloalveolar compo-
nent, which account for approximately 20% of 
cases of early-stage NSCLC — have a much better 
prognosis than do other subtypes.2 Potti et al. did 
not consider these adenocarcinoma subtypes.
In addition, the literature3 and our recent work 
demonstrate that the histologic grade is a signifi-
cant predictor of both tumor recurrence and sur-
vival,4 and there is a high correlation between 
histologic features and gene-expression profiles.5 
Our work also shows that incorporating the ade-
nocarcinoma subtype and histologic grade into 
clinical models would provide a prediction very 
similar to that of a well-validated, 50-gene panel 
for survival.5
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